По вашему запросу найдено документов: 2647
Страница 2 из 265
Construction and immunogenicity of a novel multivalent vaccine prototype based on conserved influenza virus antigens health. More effective vaccination strategies aimed at inducing broad cross-protection not only against
Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes current trend in the design of universal flu vaccines is the construction of recombinant proteins based
Prevention of Influenza A(H7N9) and Bacterial Infections in Mice Using Intranasal Immunization With Live Influenza Vaccine and the Group B Streptococcus Recombinant Polypeptides vaccine (LAIV) and group B streptococcus (GBS) recombinant polypeptides against potential pandemic H7N9
Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors target for the development of a universal vaccine against influenza because M2e sequences are highly
Production of hybrid recombinant protein flu-chim, containing influenza viruses A and B major epitopes to millions in a possible influenza pandemic. Vaccination is the most cost-effective way to reduce
Designing transmissible viral vaccines for evolutionary robustness and maximum efficiency is the development of recombinant viral vaccines that are transmissible, and thus capable of self
New approaches to allergen-specific immunotherapy (ASIT): development of a recombinant vaccine against birch pollen allergy; [Новые подходы к аллерген-специфической иммунотерапии (АСИТ): разработка рекомбинантной вакцины от аллергии на пыльцу березы] and information on the development of an innovative recombinant vaccine for the treatment of birch pollen allergy
Prime-boost vaccination with a combination of proteosome-degradable and wild-type forms of two influenza proteins leads to augmented CTL response, we hypothesized that a recombinant vaccine utilizing a combination of proteosome
Evaluation in mouse model of combined virus-bacterial vaccine based on attenuated influenza A(H7N3) virus and the group B streptococcus recombinant polypeptides attenuated influenza vaccine and recombinant polypeptides based on group B Streptococcus surface proteins
Safety and immunogenicity of the gamtbvac, the recombinant subunit tuberculosis vaccine candidate: A phase II, multi-center, double-blind, randomized, placebo-controlled studyGamTBvac is a candidate tuberculosis vaccine with two fusion proteins, containing Ag85a, ESAT6, CFP
Страница 2 из 265
Фасеты
Партнеры
Индексация
